| 1. Executive Summary |
| 2. Global HLA Typing and HLA Antibody Testing Market Introduction |
| 2.1. Global HLA Typing and HLA Antibody Testing Market – Taxonomy |
| 2.2. Global HLA Typing and HLA Antibody Testing Market –Definitions |
| 2.2.1. HLA Typing |
| 2.2.2. HLA Antibody Testing |
| 2.2.3. Region |
| 3. Global HLA Typing and HLA Antibody Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Epitope Analysis |
| 3.6. Reimbursement Scenario in USA and Europe |
| 3.7. Global HLA Typing and HLA Antibody Testing Market Dynamic Factors - Impact Analysis |
| 3.8. Number of Transplantations in USA and Europe |
| 3.9. New Product Launches |
| 3.10. Licensing, Mergers and Acquisitions |
| 4. Global HLA Typing and HLA Antibody Testing Market Analysis, 2017 – 2021 and Forecast, 2022 - 2028 |
| 4.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global HLA Typing and HLA Antibody Testing Market, By HLA Typing, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1. Lab Type |
| 5.1.1. In Lab |
| 5.1.1.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Out Sourced |
| 5.1.2.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3. Market Opportunity Analysis |
| 5.2. Typing Technology |
| 5.2.1. qPCR |
| 5.2.1.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.3. Market Opportunity Analysis |
| 5.2.2. SSO |
| 5.2.2.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.2.3. Market Opportunity Analysis |
| 5.2.3. NGS |
| 5.2.3.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3.3. Market Opportunity Analysis |
| 5.3. Type |
| 5.3.1. Patient |
| 5.3.1.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.1.3. Market Opportunity Analysis |
| 5.3.2. Registry |
| 5.3.2.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.2.3. Market Opportunity Analysis |
| 6. Global HLA Typing and HLA Antibody Testing Market, By HLA Antibody Testing, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.1. Screening |
| 6.1.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. PRA (Panel Reactive Antibody) |
| 6.2.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Single Antigen |
| 6.3.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Post Transplant Test |
| 6.4.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global HLA Typing and HLA Antibody Testing Market Forecast, By Region, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. RoW |
| 7.4.1. Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Global HLA Typing and HLA Antibody Testing Market - Opportunity Analysis Index, By HLA Typing, Antibody Testing, and Region, 2022 - 2028 |
| 8. North America HLA Typing and HLA Antibody Testing Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 8.1. HLA Typing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Lab Type |
| 8.1.1.1. In Lab |
| 8.1.1.2. Outsource |
| 8.1.2. Typing Technology |
| 8.1.2.1. qPCR |
| 8.1.2.2. SSO |
| 8.1.2.3. NGS |
| 8.1.3. Type |
| 8.1.3.1. Patient |
| 8.1.3.2. Registry |
| 8.2. HLA Antibody Testing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1. Screening |
| 8.2.2. PRA (Panel Reactive Antibodies) |
| 8.2.3. Single Antigen |
| 8.2.4. Post Transplant |
| 8.3. Country Analysis 2017 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. U.S. |
| 8.3.2. Canada |
| 8.4. North America HLA Typing and HLA Antibody Testing Market - Opportunity Analysis Index, By HLA Typing, Antibody Testing, and Country, 2019-2025 |
| 8.5. North America HLA Typing and HLA Antibody Testing Market Dynamics – Trends |
| 9. Europe HLA Typing and HLA Antibody Testing Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 9.1. HLA Typing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Lab Type |
| 9.1.1.1. In Lab |
| 9.1.1.2. Outsource |
| 9.1.2. Typing Technology |
| 9.1.2.1. qPCR |
| 9.1.2.2. SSO |
| 9.1.2.3. NGS |
| 9.1.3. Type |
| 9.1.3.1. Patient |
| 9.1.3.2. Registry |
| 9.2. HLA Antibody Testing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Screening |
| 9.2.2. PRA (Panel Reactive Antibodies) |
| 9.2.3. Single Antigen |
| 9.2.4. Post Transplant |
| 9.3. Country Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. Spain |
| 9.3.4. Italy |
| 9.3.5. France |
| 9.3.6. Rest of Europe |
| 9.4. Europe HLA Typing and HLA Antibody Testing Market - Opportunity Analysis Index, By HLA Typing, Antibody Testing, and Country, 2019-2025 |
| 9.5. Europe HLA Typing and HLA Antibody Testing Market Dynamics – Trends |
| 10. Asia-Pacific HLA Typing and HLA Antibody Testing Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 10.1. HLA Typing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Lab Type |
| 10.1.1.1. In Lab |
| 10.1.1.2. Outsource |
| 10.1.2. Typing Technology |
| 10.1.2.1. qPCR |
| 10.1.2.2. SSO |
| 10.1.2.3. NGS |
| 10.1.3. Type |
| 10.1.3.1. Patient |
| 10.1.3.2. Registry |
| 10.2. HLA Antibody Testing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Screening |
| 10.2.2. PRA (Panel Reactive Antibodies) |
| 10.2.3. Single Antigen |
| 10.2.4. Post Transplant |
| 10.3. Country Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Japan |
| 10.3.2. China |
| 10.3.3. India |
| 10.3.4. Australia and New Zealand |
| 10.3.5. Rest of Asia-Pacific |
| 10.4. Asia-Pacific HLA Typing and HLA Antibody Testing Market - Opportunity Analysis Index, By HLA Typing, Antibody Testing, and Country, 2019-2025 |
| 10.5. Asia-Pacific HLA Typing and HLA Antibody Testing Market Dynamics – Trends |
| 11. RoW HLA Typing and HLA Antibody Testing Market Analysis, 2017-2018 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
| 11.1. HLA Typing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Lab Type |
| 11.1.1.1. In Lab |
| 11.1.1.2. Outsource |
| 11.1.2. Typing Technology |
| 11.1.2.1. qPCR |
| 11.1.2.2. SSO |
| 11.1.2.3. NGS |
| 11.1.3. Type |
| 11.1.3.1. Patient |
| 11.1.3.2. Registry |
| 11.2. HLA Antibody Testing Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Screening |
| 11.2.2. PRA (Panel Reactive Antibodies) |
| 11.2.3. Single Antigen |
| 11.2.4. Post Transplant |
| 11.3. Country Analysis 2017-2018 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Saudi Arabia |
| 11.3.2. Turkey |
| 11.3.3. Brazil |
| 11.3.4. Rest of RoW |
| 11.4. RoW HLA Typing and HLA Antibody Testing Market - Opportunity Analysis Index, By HLA Typing, Antibody Testing, and Country, 2019-2025 |
| 11.5. RoW HLA Typing and HLA Antibody Testing Market Dynamics – Trends |
| 12. Competition Landscape |
| 12.1. Strategic Dashboard of Top Market Players |
| 12.2. Company Profiles (Introduction, Financial Analysis, Drug Class & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 12.2.1. One Lamba |
| 12.2.2. Immucor Inc., |
| 12.2.3. Bio-Rad Laboratories, Inc |
| 12.2.4. F. Hoffmann-La Roche Ltd |
| 12.2.5. QIAGEN N.V |
| 12.2.6. One Lambda (Thermo Fisher Scientific Inc.) |
| 12.2.7. Becton, Dickinson and Company |
| 12.2.8. BAG Health Care GmbH |
| 12.2.9. CareDx Inc |
| 13. Research Methodology |
| 14. Key Assumptions and Acronyms |
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
- One Lamba
- Immucor Inc.,
- Bio-Rad Laboratories, Inc
- QIAGEN N.V
- One Lambda (Thermo Fisher Scientific Inc.)
- Becton, Dickinson and Company
- BAG Health Care GmbH
- CareDx Inc
- Hoffmann-La Roche Ltd